Related Experiment Videos
Exercise training does not alter cytochrome P-450 content and microsomal metabolism
T J Michaud1, K A Bachmann, F F Andres
1Department of Health Promotion and Human Performance, University of Toledo, OH 43606.
Medicine and Science in Sports and Exercise
|August 1, 1994
Summary
Strenuous endurance training did not change liver cytochrome P-450 content or drug metabolism in rats. This suggests exercise capacity does not impact how the body processes certain medications.
Area of Science:
- Pharmacology
- Exercise Physiology
- Biochemistry
Background:
- Hepatic cytochrome P-450 enzymes are crucial for drug metabolism.
- The impact of endurance exercise on these enzymes is not fully understood.
- Understanding this relationship is important for predicting drug efficacy and safety in athletes.
Purpose of the Study:
- To investigate if increased endurance exercise capacity affects total hepatic cytochrome P-450 content.
- To determine if endurance training alters drug metabolism mediated by specific cytochrome P-450 enzymes (CYP1A and CYP2B).
Main Methods:
- Adult male Sprague-Dawley rats were divided into control and endurance-trained groups.
- The endurance-trained group underwent progressive training for 11 weeks.
- Probe drugs (theophylline for CYP1A, antipyrine for CYP2B) were administered to assess drug metabolism.
Main Results:
- Endurance training significantly increased soleus muscle citrate synthase activity, confirming enhanced exercise capacity.
- No significant differences were observed in total liver cytochrome P-450 content between control and trained rats.
- Plasma clearances of theophylline and antipyrine were not significantly different between the groups, indicating unchanged CYP1A and CYP2B activity.
Conclusions:
- Eleven weeks of strenuous endurance training did not alter total hepatic cytochrome P-450 content in rats.
- The activity of CYP1A and CYP2B mediated drug metabolism remained unaffected by endurance training.
- Increased endurance exercise capacity does not appear to influence hepatic drug-metabolizing enzyme activity in this model.